265 related articles for article (PubMed ID: 22014187)
1. Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis.
Andersson CK; Andersson-Sjöland A; Mori M; Hallgren O; Pardo A; Eriksson L; Bjermer L; Löfdahl CG; Selman M; Westergren-Thorsson G; Erjefält JS
Respir Res; 2011 Oct; 12(1):139. PubMed ID: 22014187
[TBL] [Abstract][Full Text] [Related]
2. Decline in Mast Cell Density During Diffuse Alveolar Damage in Idiopathic Pulmonary Fibrosis.
Salonen J; Kreus M; Lehtonen S; Vähänikkilä H; Purokivi M; Kaarteenaho R
Inflammation; 2022 Apr; 45(2):768-779. PubMed ID: 34686945
[TBL] [Abstract][Full Text] [Related]
3. Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis.
Cha SI; Chang CS; Kim EK; Lee JW; Matthay MA; Golden JA; Elicker BM; Jones K; Collard HR; Wolters PJ
Histopathology; 2012 Jul; 61(1):98-106. PubMed ID: 22394225
[TBL] [Abstract][Full Text] [Related]
4. Dynamically upregulated mast cell CPA3 patterns in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Siddhuraj P; Jönsson J; Alyamani M; Prabhala P; Magnusson M; Lindstedt S; Erjefält JS
Front Immunol; 2022; 13():924244. PubMed ID: 35983043
[TBL] [Abstract][Full Text] [Related]
5. Uncontrolled asthmatics have increased FceRI
Andersson CK; Weitoft M; Rydell-Törmänen K; Bjermer L; Westergren-Thorsson G; Erjefält JS
Clin Exp Allergy; 2018 Mar; 48(3):266-277. PubMed ID: 29336501
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa.
Hubeau C; Lorenzato M; Couetil JP; Hubert D; Dusser D; Puchelle E; Gaillard D
Clin Exp Immunol; 2001 Apr; 124(1):69-76. PubMed ID: 11359444
[TBL] [Abstract][Full Text] [Related]
7. Association of Lung Inflammatory Cells with Small Airways Function and Exhaled Breath Markers in Smokers - Is There a Specific Role for Mast Cells?
Nussbaumer-Ochsner Y; Stolk J; Ferraz da Silva LF; van Schadewijk A; de Jeu RC; Prins FA; Mauad T; Rabe KF; Hiemstra PS
PLoS One; 2015; 10(6):e0129426. PubMed ID: 26069967
[TBL] [Abstract][Full Text] [Related]
8. The Role of Mast Cells in IgE-Independent Lung Diseases.
Komi DEA; Mortaz E; Amani S; Tiotiu A; Folkerts G; Adcock IM
Clin Rev Allergy Immunol; 2020 Jun; 58(3):377-387. PubMed ID: 32086776
[TBL] [Abstract][Full Text] [Related]
9. Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression.
Gotis-Graham I; McNeil HP
Arthritis Rheum; 1997 Mar; 40(3):479-89. PubMed ID: 9082936
[TBL] [Abstract][Full Text] [Related]
10. Mast cell phenotypes in the allograft after lung transplantation.
Banga A; Han Y; Wang X; Hsieh FH
Clin Transplant; 2016 Jul; 30(7):845-51. PubMed ID: 27146340
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of transforming growth factor-β signalling and regulatory molecules in human and canine idiopathic pulmonary fibrosis.
Lilja-Maula L; Syrjä P; Laurila HP; Sutinen E; Rönty M; Koli K; Rajamäki MM; Myllärniemi M
J Comp Pathol; 2014 May; 150(4):399-407. PubMed ID: 24529509
[TBL] [Abstract][Full Text] [Related]
12. Mechanical stress-induced mast cell degranulation activates TGF-β1 signalling pathway in pulmonary fibrosis.
Shimbori C; Upagupta C; Bellaye PS; Ayaub EA; Sato S; Yanagihara T; Zhou Q; Ognjanovic A; Ask K; Gauldie J; Forsythe P; Kolb MRJ
Thorax; 2019 May; 74(5):455-465. PubMed ID: 30808717
[TBL] [Abstract][Full Text] [Related]
13. Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study.
Verleden SE; Tanabe N; McDonough JE; Vasilescu DM; Xu F; Wuyts WA; Piloni D; De Sadeleer L; Willems S; Mai C; Hostens J; Cooper JD; Verbeken EK; Verschakelen J; Galban CJ; Van Raemdonck DE; Colby TV; Decramer M; Verleden GM; Kaminski N; Hackett TL; Vanaudenaerde BM; Hogg JC
Lancet Respir Med; 2020 Jun; 8(6):573-584. PubMed ID: 32061334
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects.
Overed-Sayer C; Miranda E; Dunmore R; Liarte Marin E; Beloki L; Rassl D; Parfrey H; Carruthers A; Chahboub A; Koch S; Güler-Gane G; Kuziora M; Lewis A; Murray L; May R; Clarke D
Thorax; 2020 Sep; 75(9):754-763. PubMed ID: 32709610
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin free light chains are increased in hypersensitivity pneumonitis and idiopathic pulmonary fibrosis.
Groot Kormelink T; Pardo A; Knipping K; Buendía-Roldán I; García-de-Alba C; Blokhuis BR; Selman M; Redegeld FA
PLoS One; 2011; 6(9):e25392. PubMed ID: 21980441
[TBL] [Abstract][Full Text] [Related]
16. Multi-Modal Characterization of Monocytes in Idiopathic Pulmonary Fibrosis Reveals a Primed Type I Interferon Immune Phenotype.
Fraser E; Denney L; Antanaviciute A; Blirando K; Vuppusetty C; Zheng Y; Repapi E; Iotchkova V; Taylor S; Ashley N; St Noble V; Benamore R; Hoyles R; Clelland C; Rastrick JMD; Hardman CS; Alham NK; Rigby RE; Simmons A; Rehwinkel J; Ho LP
Front Immunol; 2021; 12():623430. PubMed ID: 33746960
[TBL] [Abstract][Full Text] [Related]
17. Increased Expiratory Computed Tomography Density Reveals Possible Abnormalities in Radiologically Preserved Lung Parenchyma in Idiopathic Pulmonary Fibrosis.
Petroulia V; Funke M; Zumstein P; Berezowska S; Ebner L; Geiser T; Torbica N; Heverhagen J; Poellinger A
Invest Radiol; 2018 Jan; 53(1):45-51. PubMed ID: 28817393
[TBL] [Abstract][Full Text] [Related]
18. Immunofluorescent staining for mast cells in idiopathic pulmonary fibrosis: quantification and evidence for extracellular release of mast cell tryptase.
Hunt LW; Colby TV; Weiler DA; Sur S; Butterfield JH
Mayo Clin Proc; 1992 Oct; 67(10):941-8. PubMed ID: 1434854
[TBL] [Abstract][Full Text] [Related]
19. Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis.
Westergren-Thorsson G; Hedström U; Nybom A; Tykesson E; Åhrman E; Hornfelt M; Maccarana M; van Kuppevelt TH; Dellgren G; Wildt M; Zhou XH; Eriksson L; Bjermer L; Hallgren O
Int J Biochem Cell Biol; 2017 Feb; 83():27-38. PubMed ID: 27974233
[TBL] [Abstract][Full Text] [Related]
20. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]